Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
1992-8-14
pubmed:abstractText
In human epidermal carcinoma A431 cells, the beta subunit of casein kinase II is phosphorylated at an autophosphorylation site and at serine 209 which can be phosphorylated in vitro by p34cdc2 (Litchfield, D. W., Lozeman, F. J., Cicirelli, M. F., Harrylock, M., Ericsson, L. H., Piening, C. J., and Krebs, E. G. (1991) J. Biol. Chem. 266, 20380-20389). Given the importance of p34cdc2 in the regulation of cell cycle events, we were interested in examining the phosphorylation of casein kinase II during different stages of the cell cycle. In this study it is demonstrated that the extent of phosphorylation of serine 209 in the beta subunit is significantly increased relative to phosphorylation of the autophosphorylation site when chicken bursal lymphoma BK3A cells are arrested at mitosis by nocodazole treatment. This result suggests that serine 209 is a likely physiological target for p34cdc2. In addition, the alpha subunit of casein kinase II also undergoes dramatic phosphorylation with an associated alteration in its electrophoretic mobility when BK3A cells or human Jurkat cells are arrested with nocodazole. Phosphopeptide mapping studies indicate that p34cdc2 can phosphorylate in vitro the same peptides on the alpha subunit that are phosphorylated in cells arrested at mitosis. These phosphorylation sites were localized to serine and threonine residues in the carboxyl-terminal domain of alpha. Taken together, the results of this study indicate that casein kinase II is a probable physiological substrate for p34cdc2 and suggest that its functional properties could be affected in a cell cycle-dependent manner.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
267
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13943-51
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:1629192-Animals, pubmed-meshheading:1629192-Antibodies, pubmed-meshheading:1629192-CDC2 Protein Kinase, pubmed-meshheading:1629192-Carcinoma, Squamous Cell, pubmed-meshheading:1629192-Casein Kinase II, pubmed-meshheading:1629192-Cattle, pubmed-meshheading:1629192-Cell Line, pubmed-meshheading:1629192-Chickens, pubmed-meshheading:1629192-Chromatography, Ion Exchange, pubmed-meshheading:1629192-Humans, pubmed-meshheading:1629192-Lymphoma, pubmed-meshheading:1629192-Macromolecular Substances, pubmed-meshheading:1629192-Male, pubmed-meshheading:1629192-Mitosis, pubmed-meshheading:1629192-Peptide Mapping, pubmed-meshheading:1629192-Phosphopeptides, pubmed-meshheading:1629192-Phosphorylation, pubmed-meshheading:1629192-Protein-Serine-Threonine Kinases, pubmed-meshheading:1629192-Testis, pubmed-meshheading:1629192-Trypsin
pubmed:year
1992
pubmed:articleTitle
Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis.
pubmed:affiliation
Department of Pharmacology, University of Washington, Seattle 98195.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't